CI Group PCL
SET:CIG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CI Group PCL
SET:CIG
|
TH |
|
Nan Pao Resins Chemical Co Ltd
TWSE:4766
|
TW |
|
B
|
Berkshire Hathaway Inc
SWB:BRH
|
US |
|
Z
|
Zevia PBC
NYSE:ZVIA
|
US |
|
Japan Tobacco Inc
TSE:2914
|
JP |
|
Comet Holding AG
SIX:COTN
|
CH |
|
Ottogi Corp
KRX:007310
|
KR |
|
GYP Properties Ltd
SGX:AWS
|
SG |
|
First US Bancshares Inc
NASDAQ:FUSB
|
US |
|
Wills Inc
TSE:4482
|
JP |
|
Brundage-Bone Concrete Pumping Holdings Inc
NASDAQ:BBCP
|
US |
|
M
|
Meridian Bioscience Inc
LSE:0K0K
|
US |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SZSE:002287
|
CN |
|
KMD Brands Ltd
NZX:KMD
|
NZ |
Balance Sheet
Balance Sheet Decomposition
CI Group PCL
CI Group PCL
Balance Sheet
CI Group PCL
| Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Cash & Cash Equivalents |
21
|
26
|
18
|
19
|
56
|
47
|
49
|
45
|
8
|
9
|
14
|
149
|
48
|
51
|
32
|
21
|
10
|
31
|
10
|
30
|
28
|
4
|
10
|
|
| Cash Equivalents |
21
|
26
|
18
|
19
|
56
|
47
|
49
|
45
|
8
|
9
|
14
|
149
|
48
|
51
|
32
|
21
|
10
|
31
|
10
|
30
|
28
|
4
|
10
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
119
|
92
|
88
|
80
|
81
|
81
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
102
|
169
|
225
|
244
|
316
|
344
|
283
|
316
|
242
|
218
|
412
|
266
|
238
|
267
|
260
|
258
|
197
|
206
|
210
|
203
|
320
|
116
|
169
|
|
| Accounts Receivables |
102
|
169
|
225
|
244
|
316
|
344
|
244
|
304
|
229
|
206
|
314
|
227
|
169
|
219
|
204
|
199
|
197
|
204
|
200
|
202
|
316
|
113
|
167
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
39
|
12
|
12
|
12
|
98
|
39
|
69
|
49
|
57
|
59
|
0
|
2
|
10
|
1
|
4
|
3
|
3
|
|
| Inventory |
44
|
92
|
141
|
196
|
220
|
257
|
232
|
301
|
368
|
226
|
193
|
170
|
181
|
128
|
178
|
179
|
124
|
92
|
131
|
126
|
64
|
56
|
77
|
|
| Other Current Assets |
11
|
3
|
22
|
5
|
6
|
27
|
37
|
33
|
41
|
22
|
14
|
14
|
2
|
4
|
10
|
49
|
128
|
11
|
11
|
21
|
34
|
0
|
3
|
|
| Total Current Assets |
178
|
290
|
406
|
464
|
717
|
767
|
690
|
775
|
739
|
555
|
634
|
601
|
470
|
451
|
481
|
507
|
459
|
339
|
362
|
380
|
412
|
176
|
260
|
|
| PP&E Net |
129
|
131
|
281
|
329
|
413
|
931
|
892
|
784
|
715
|
630
|
569
|
529
|
531
|
527
|
502
|
428
|
400
|
384
|
354
|
281
|
185
|
154
|
137
|
|
| PP&E Gross |
129
|
131
|
281
|
329
|
413
|
931
|
892
|
784
|
715
|
630
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
103
|
121
|
145
|
174
|
213
|
294
|
373
|
531
|
635
|
721
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
7
|
5
|
4
|
2
|
1
|
15
|
17
|
17
|
14
|
13
|
11
|
8
|
7
|
4
|
3
|
5
|
3
|
2
|
4
|
3
|
1
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
0
|
0
|
0
|
0
|
0
|
0
|
28
|
27
|
27
|
28
|
30
|
27
|
|
| Long-Term Investments |
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
17
|
15
|
0
|
69
|
91
|
91
|
91
|
180
|
55
|
63
|
56
|
52
|
102
|
44
|
1
|
|
| Other Long-Term Assets |
28
|
28
|
28
|
29
|
59
|
51
|
26
|
28
|
26
|
25
|
61
|
95
|
76
|
40
|
77
|
48
|
105
|
59
|
60
|
35
|
546
|
473
|
463
|
|
| Total Assets |
341
N/A
|
454
+33%
|
718
+58%
|
827
+15%
|
1 190
+44%
|
1 765
+48%
|
1 623
-8%
|
1 604
-1%
|
1 512
-6%
|
1 238
-18%
|
1 291
+4%
|
1 304
+1%
|
1 174
-10%
|
1 113
-5%
|
1 154
+4%
|
1 168
+1%
|
1 022
-13%
|
875
-14%
|
864
-1%
|
779
-10%
|
1 273
+63%
|
878
-31%
|
888
+1%
|
|
| Liabilities | ||||||||||||||||||||||||
| Accounts Payable |
68
|
135
|
151
|
125
|
159
|
140
|
191
|
185
|
166
|
137
|
185
|
146
|
129
|
157
|
207
|
248
|
227
|
205
|
258
|
228
|
134
|
203
|
387
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
86
|
97
|
82
|
221
|
50
|
472
|
400
|
511
|
589
|
407
|
286
|
274
|
205
|
116
|
136
|
150
|
206
|
207
|
258
|
336
|
207
|
165
|
121
|
|
| Current Portion of Long-Term Debt |
4
|
10
|
40
|
59
|
60
|
89
|
72
|
51
|
174
|
25
|
71
|
46
|
3
|
1
|
1
|
1
|
0
|
0
|
5
|
2
|
2
|
1
|
1
|
|
| Other Current Liabilities |
26
|
25
|
16
|
12
|
22
|
30
|
19
|
19
|
39
|
204
|
240
|
4
|
9
|
10
|
14
|
24
|
21
|
23
|
38
|
40
|
9
|
6
|
15
|
|
| Total Current Liabilities |
184
|
266
|
289
|
417
|
290
|
730
|
682
|
766
|
969
|
775
|
782
|
470
|
347
|
285
|
359
|
423
|
453
|
434
|
560
|
606
|
352
|
375
|
524
|
|
| Long-Term Debt |
15
|
20
|
151
|
135
|
169
|
318
|
256
|
211
|
44
|
21
|
40
|
7
|
4
|
3
|
1
|
0
|
1
|
9
|
8
|
6
|
25
|
9
|
17
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
1
|
1
|
2
|
6
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
10
|
10
|
23
|
27
|
31
|
30
|
33
|
37
|
43
|
46
|
74
|
69
|
56
|
56
|
56
|
44
|
45
|
|
| Total Liabilities |
198
N/A
|
286
+44%
|
439
+54%
|
552
+26%
|
460
-17%
|
1 048
+128%
|
947
-10%
|
988
+4%
|
1 036
+5%
|
823
-21%
|
852
+4%
|
507
-40%
|
384
-24%
|
324
-16%
|
402
+24%
|
469
+17%
|
529
+13%
|
512
-3%
|
629
+23%
|
666
+6%
|
434
-35%
|
431
-1%
|
592
+38%
|
|
| Equity | ||||||||||||||||||||||||
| Common Stock |
120
|
120
|
165
|
165
|
251
|
252
|
252
|
274
|
276
|
300
|
301
|
432
|
432
|
432
|
432
|
432
|
432
|
432
|
432
|
432
|
1 373
|
1 806
|
1 868
|
|
| Retained Earnings |
22
|
48
|
35
|
32
|
73
|
56
|
0
|
106
|
250
|
335
|
312
|
216
|
222
|
224
|
261
|
314
|
520
|
651
|
778
|
901
|
884
|
1 317
|
1 470
|
|
| Additional Paid In Capital |
0
|
0
|
79
|
79
|
407
|
409
|
425
|
449
|
449
|
449
|
449
|
581
|
581
|
581
|
581
|
581
|
581
|
581
|
581
|
581
|
581
|
23
|
80
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
231
|
19
|
22
|
|
| Total Equity |
142
N/A
|
168
+18%
|
279
+66%
|
276
-1%
|
730
+165%
|
716
-2%
|
676
-6%
|
617
-9%
|
475
-23%
|
415
-13%
|
438
+6%
|
797
+82%
|
791
-1%
|
789
0%
|
752
-5%
|
699
-7%
|
493
-29%
|
362
-27%
|
235
-35%
|
112
-52%
|
839
+647%
|
447
-47%
|
295
-34%
|
|
| Total Liabilities & Equity |
341
N/A
|
454
+33%
|
718
+58%
|
827
+15%
|
1 190
+44%
|
1 765
+48%
|
1 623
-8%
|
1 604
-1%
|
1 512
-6%
|
1 238
-18%
|
1 291
+4%
|
1 304
+1%
|
1 174
-10%
|
1 113
-5%
|
1 154
+4%
|
1 168
+1%
|
1 022
-13%
|
875
-14%
|
864
-1%
|
779
-10%
|
1 273
+63%
|
878
-31%
|
888
+1%
|
|
| Shares Outstanding | ||||||||||||||||||||||||
| Common Shares Outstanding |
240
|
240
|
330
|
330
|
501
|
503
|
503
|
548
|
552
|
600
|
602
|
865
|
865
|
865
|
865
|
865
|
865
|
865
|
865
|
865
|
2 747
|
3 612
|
3 737
|
|